PF-04995274
- Generic Name
- PF-04995274
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H32N2O6
- CAS Number
- 1331782-27-4
- Unique Ingredient Identifier
- XI179PG9LV
- Background
Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274).
- Associated Conditions
- -
- Associated Therapies
- -
PF-04995274 and Emotional Processing in Treatment Resistant Depression
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 54
- Registration Number
- NCT03515733
- Locations
- 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom
PF-04995274 and Emotional Processing in Un-medicated Depression
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 90
- Registration Number
- NCT03516604
- Locations
- 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom
Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2018-12-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT01193062
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2011-06-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 8
- Registration Number
- NCT01173757
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Following A Single Dose Of PF-04995274 In Healthy Adult Volunteers
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2010-09-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT01091272
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath